Silver Med. v. Comm'r

147 T.C. No. 18, 112 T.C.M. 4809, 2016 U.S. Tax Ct. LEXIS 36
CourtUnited States Tax Court
DecidedDecember 19, 2016
DocketDocket No. 2267-14.
StatusPublished
Cited by1 cases

This text of 147 T.C. No. 18 (Silver Med. v. Comm'r) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Silver Med. v. Comm'r, 147 T.C. No. 18, 112 T.C.M. 4809, 2016 U.S. Tax Ct. LEXIS 36 (tax 2016).

Opinion

SILVER MEDICAL, INC., Petitioner v. COMMISSIONER OF INTERNAL REVENUE, Respondent
Silver Med. v. Comm'r
Docket No. 2267-14.
United States Tax Court
2016 U.S. Tax Ct. LEXIS 36; 147 T.C. No. 18;
December 19, 2016, Filed

Decision will be entered under Rule 155.

P, a calendar year taxpayer, applied to have its investments in a therapeutic discovery project certified under I.R.C. sec. 48D. On its application P requested certification of investments made in its 2009 and 2010 tax years. While certification generally results in a tax credit, P elected to receive cash grants in lieu of a credit. P received certification. P then changed its 2010 tax year from a calendar year to a short tax year ending November 30, 2010. P filed a second application under I.R.C. sec. 48D requesting certification of investments made in its fiscal year ending (FYE) November 30, 2011. P's second application did not result in certification.

Held: P is not entitled to a grant related to investments made after the 2010 calendar year because P was not certified to make qualified investments after that year.

Held, further, grant funds attributable to estimated qualified investments that exceeded actual investments made during the 2010 calendar year must be recaptured as tax.

Held, further, P must recapture the excess grant funds for its FYE November 30, 2011, because that year includes the period in which the relevant grant was made.

*36 James H. Silver (an officer), for petitioner.
Audra M. Dineen, for respondent.
VASQUEZ, Judge.

VASQUEZ

VASQUEZ, Judge: Respondent determined a deficiency in petitioner's Federal income tax of $41,032 for the fiscal year ending (FYE) November 30, 2011, and an accuracy-related penalty under section 6662(a) of $8,206.1 After a concession,2 the issues for decision are: (1) whether petitioner must recapture as tax $41,032 previously received as a grant and, if so, (2) whether recapture should occur for petitioner's FYE November 30, 2011.

FINDINGS OF FACT

Some of the facts have been stipulated and are so found. The stipulation of facts and the attached exhibits are incorporated by this reference. Petitioner is a corporation organized under Delaware law. At the time the petition was timely filed, petitioner's principal place of business was Palo Alto, California.

Petitioner is a medical device company focused on developing a system for more efficiently detecting cerebral ischemia (i.e., stroke) in patients undergoing surgery. During all relevant times James H. Silver served as petitioner's president. Mr. Silver holds a doctorate in chemical engineering and has over 17 years of experience in the medical device industry.*37

Shortly after petitioner timely filed its 2009 return, the Patient Protection and Affordable Care Act (ACA), Pub. L. No. 111-148, 124 Stat. 119 (2010), was enacted. ACA sec. 9023(a), 124 Stat. at 877, established a new section 48D in the Internal Revenue Code allowing a taxpayer to claim a tax credit (or alternatively apply for a cash grant in lieu of a credit) if the taxpayer made investments in a "qualifying therapeutic discovery project" (QTDP). The credit or grant was limited to 50% of qualified investments made in taxable years beginning in 2009 or 2010. Sec. 48D(a), (b)(5).

Pursuant to section 48D(d)(1)(A), the Secretary3 and the Internal Revenue Service (IRS) jointly published Notice 2010-45, 2010-23 I.R.B. 734, establishing the QTDP program and describing the process by which taxpayers could apply to have a therapeutic discovery project certified as eligible for a credit or grant. The IRS also released Form 8942, Application for Certification of Qualified Investments Eligible for Credits and Grants Under the Qualifying Therapeutic Discovery Project Program, which allowed taxpayers to apply for the credit or grant.

On the Form 8942, a taxpayer had to describe its therapeutic discovery project and list its investment in the project for each year for which it was claiming the credit or requesting a grant. The IRS (in consultation with the Department of Health*38 and Human Services) would review the application and decide whether to certify the project and the claimed investments. Notice 2010-45, sec. 5

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wang v. Comm'r
2017 T.C. Memo. 81 (U.S. Tax Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
147 T.C. No. 18, 112 T.C.M. 4809, 2016 U.S. Tax Ct. LEXIS 36, Counsel Stack Legal Research, https://law.counselstack.com/opinion/silver-med-v-commr-tax-2016.